Page 31 - 南京医科大学自然版

第45卷第11期 林书慧，钱萌森，朱 静，等. METTL3介导的KIF11 mRNA m6A修饰通过PI3K/AKT信号通路促进结
2025年11月 直肠癌进展［J］. 南京医科大学学报（自然科学版），2025，45（11）：1546-1562 ·1561 ·

526 colorectal cancer proliferation and metastasis by activat⁃
［6］ CHEN D L，WANG J H，LI Y，et al. LncRNA NEAT1 sup⁃ ing STAT3［J］. J Transl Med，2023，21（1）：418
presses cellular senescence in hepatocellular carcinoma ［19］LIU W J，ZHANG Z L，LUO X T，et al. m6A⁃mediated
via KIF11 ⁃ dependent repression of CDKN2A［J］. Clin LINC02038 inhibits colorectal cancer progression via reg⁃
Transl Med，2023，13（9）：e1418 ulation of the FAM172A/PI3K/AKT pathway via competi⁃
［7］ ZUIDHOF H R，MÜLLER C，KORTMAN G，et al. The tive binding with miR⁃552⁃5p［J］. Int J Oncol，2023，63
m6A demethylase FTO promotes C/EBPβ⁃LIP translation （1）：81
to perform oncogenic functions in breast cancer cells［J］. ［20］BAKR M，ABD ⁃ ELMAWLA M A，ELIMAM H，et al.
FEBS J，2025，292（10）：2688-2709 Telomerase RNA component lncRNA as potential diag⁃
［8］ ZHU Z M，HUO F C，SHI C，et al. METTL3 ⁃ mediated nostic biomarker promotes CRC cellular migration and
m6A modification of PAK6 drives cervical cancer progres⁃ apoptosis evasion via modulation of β⁃catenin protein lev⁃
sion through activating MAPK14［J］. Int J Biol Macromol， el［J］. Noncoding RNA Res，2023，8（3）：302-314
2025，309：142880 ［21］BIAN Y B，WANG Y，XU S F，et al. m6A modification of
［9］ ZOU J，SHI X，WU Z，ZUO S，et al. MRTX1133 attenu⁃ long non⁃coding RNA HNF1A⁃AS1 facilitates cell cycle
ates KRAS（G12D）mutated⁃colorectal cancer progression progression in colorectal cancer via IGF2BP2 ⁃ mediated
through activating ferroptosis activity via METTL14/ CCND1 mRNA stabilization［J］. Cells，2022，11（19）：
LINC02159/FOXC2 axis［J］. Transl Oncol，2025，52： 3008
102235 ［22］ZENG H，HOU Y X，ZHOU X Y，et al. Cancer⁃associated
［10］ZHOU D，TANG W W，XU Y D，et al. METTL3/YTHDF2 fibroblasts facilitate premetastatic niche formation
m6A axis accelerates colorectal carcinogenesis through through lncRNA SNHG5⁃mediated angiogenesis and vas⁃
epigenetically suppressing YPEL5［J］. Mol Oncol，2021， cular permeability in breast cancer［J］. Theranostics，
15（8）：2172-2184 2022，12（17）：7351-7370
［11］ZHAO S，SONG P，ZHOU G，et al. METTL3 promotes the ［23］MU H Y，CHEN J Z，HUANG W J，et al. OmicShare tools：
malignancy of non⁃small cell lung cancer by N6⁃methyl⁃ a zero⁃code interactive online platform for biological data
adenosine modifying SFRP2［J］. Cancer Gene Ther， analysis and visualization［J］. Imeta，2024，3（5）：e228
2023，30（8）：1094-1104 ［24］ZHU T Y，HONG L L，LING Z Q. Oncofetal protein
［12］XUE L，LI J，LIN Y H，et al. m6A transferase METTL3⁃in⁃ IGF2BPs in human cancer：functions，mechanisms and
duced lncRNA ABHD11⁃AS1 promotes the Warburg ef⁃ therapeutic potential［J］. Biomark Res，2023，11（1）：62
fect of non ⁃ small ⁃ cell lung cancer［J］. J Cell Physiol， ［25］WEI Y Y，JIANG Y Z，ZOU F，et al. Activation of PI3K/
2021，236（4）：2649-2658 Akt pathway by CD133⁃p85 interaction promotes tumori⁃
［13］WANG J Y，CHEN L J，QIANG P. The role of IGF 2BP2， genic capacity of glioma stem cells［J］. Proc Natl Acad
an m6A reader gene，in human metabolic diseases and Sci USA，2013，110（17）：6829-6834
cancers［J］. Cancer Cell Int，2021，21（1）：99 ［26］ZHU Y L，YU J W，WANG S L，et al. Overexpression of
［14］WANG J Y，ZHU M X，ZHU J H，et al. HES1 promotes CD133 enhances chemoresistance to 5⁃fluorouracil by ac⁃
aerobic glycolysis and cancer progression of colorectal tivating the PI3K/Akt/p70S6K pathway in gastric cancer
cancer via IGF2BP2⁃mediated GLUT1 m6A modification［J］. cells［J］. Oncol Rep，2014，32（6）：2437-2444
Cell Death Discov，2023，9（1）：411 ［27］ZHU M，YU R，LIU Y，et al. LncRNA H19 participates in
［15］HU X G，PENG W X，ZHOU H X，et al. IGF2BP2 regu⁃ leukemia inhibitory factor mediated stemness promotion
lates DANCR by serving as an N6 ⁃ methyladenosine in colorectal cancer cells［J］. Biochem Genet，2024，62
reader［J］. Cell Death Differ，2020，27（6）：1782⁃1794 （5）：3695-3708
［16］BARZEGAR BEHROOZ A，SYAHIR A，AHMAD S. ［28］DIEFENBACH R J，MACKAY J P，ARMATI P J，et al.
CD133：beyond a cancer stem cell biomarker［J］. J Drug The C⁃terminal region of the stalk domain of ubiquitous
Target，2019，27（3）：257-269 human kinesin heavy chain contains the binding site for
［17］ZHU Y L，KONG F F，ZHANG C H，et al. CD133 medi⁃ kinesin light chain［J］. Biochemistry，1998，37（47）：
ates the TGF ⁃ β1 ⁃ induced activation of the PI3K/ERK/ 16663-16670
P70S6K signaling pathway in gastric cancer cells［J］. On⁃ ［29］LUCANUS A J，YIP G W. Kinesin superfamily：roles in
col Lett，2017，14（6）：7211-7216 breast cancer，patient prognosis and therapeutics［J］. On⁃
［18］SHI Q，HE Y，HE S Y，et al. RP11⁃296E3.2 acts as an im⁃ cogene，2018，37（7）：833-838
portant molecular chaperone for YBX1 and promotes ［30］SHARP D J，ROGERS G C，SCHOLEY J M. Microtubule